Literature DB >> 29183010

Mild-to-Moderate Chronic Kidney Disease and Geriatric Outcomes: Analysis of Cross-Sectional Data from the Berlin Aging Study II.

Maximilian König1, Maik Gollasch, Dominik Spira, Nikolaus Buchmann, Werner Hopfenmüller, Elisabeth Steinhagen-Thiessen, Ilja Demuth.   

Abstract

BACKGROUND: Mild-to-moderate chronic kidney disease (CKD G3a) is prevalent in older adults. Substantial evidence suggests that individuals with advanced CKD face a high risk for common geriatric conditions, like functional impairment and cognitive decline, whereas the relationships between mild-to-moderate CKD and functional impairment and cognitive decline, but also poor nutritional status and mood disorders, are still unclear.
OBJECTIVE: The aim of this study was to explore associations between mild-to-moderate CKD and impairments in the core domains of geriatric assessment (GA) in a large cohort of community-dwelling older adults.
METHODS: This was a cross-sectional analysis of 1,476 participants of the Berlin Aging Study II. Study participants were stratified as to presence or absence of CKD G3a (estimated glomerular filtration rate [eGFR] 45-59 mL/min/1.73 m2 vs. eGFR ≥60 mL/min/1.73 m2). GA comprised the following instruments: the Activities of Daily Living Scale (ADL), the Timed up and Go (TUG), the Tinetti test (Tinetti), the Mini-Mental-State Examination (MMSE), the Geriatric Depression Scale (GDS), and the Mini Nutritional Assessment (MNA). We used logistic regression models to estimate multivariable-adjusted associations between CKD G3a and impairments in the respective domains.
RESULTS: A total of 282 subjects with mild-to-moderate CKD (CKD G3a) were identified (19.1%). Overall, the prevalence of impairments identified was higher among subjects with compared to without CKD G3a (21 vs. 15.9%, p = 0.043). In multivariable-adjusted models, CKD G3a was consistently associated with increased odds of an impaired gait performance as to the TUG (adjusted odds ratio 2.06, 95% CI 1.04-4.09). In contrast, on average, individuals with and without CKD G3a did not differ as to their results in the MMSE, the ADL, the MNA, and the GDS.
CONCLUSION: GA identified impairments in 21 versus 15.9% of older adults with and without mild-to-moderate CKD, respectively. However, except for an increased likelihood of impaired gait performance (TUG) with mild-to-moderate CKD, we did not find independent associations between mild-to-moderate CKD and geriatric conditions.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Assessment; Chronic kidney disease; Cognition; Mobility; Nutrition; Physical function

Mesh:

Year:  2017        PMID: 29183010     DOI: 10.1159/000484140

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  4 in total

1.  Kidney function and cognitive impairment among older hospitalized patients: a comparison of four glomerular filtration rate equations.

Authors:  Elisa Pierpaoli; Katia Fabi; Federica Francesca Lenci; Maddalena Ricci; Mirko Di Rosa; Graziano Onder; Stefano Volpato; Carmelinda Ruggiero; Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Aging Clin Exp Res       Date:  2019-11-15       Impact factor: 3.636

Review 2.  Skeletal Muscle Complications in Chronic Kidney Disease.

Authors:  Ashley D Troutman; Eliott Arroyo; Kenneth Lim; Ranjani N Moorthi; Keith G Avin
Journal:  Curr Osteoporos Rep       Date:  2022-09-23       Impact factor: 5.163

3.  Accidental falling in community-dwelling elderly with chronic kidney disease.

Authors:  Namiko A Goto; Marije E Hamaker; Hanna C Willems; Marianne C Verhaar; Mariëlle H Emmelot-Vonk
Journal:  Int Urol Nephrol       Date:  2018-10-15       Impact factor: 2.370

4.  Higher albumin:creatinine ratio and lower estimated glomerular filtration rate are potential risk factors for decline of physical performance in the elderly: the Cardiovascular Health Study.

Authors:  Petra Bůžková; Joshua I Barzilay; Howard A Fink; John A Robbins; Jane A Cauley; Joachim H Ix; Kenneth J Mukamal
Journal:  Clin Kidney J       Date:  2019-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.